Abstract
Mitral regurgitation (MR) is the most-common valvular heart disease in the western world. From an etiologic point of view, MR can be either organic (mainly degenerative in western countries) or functional (secondary to left ventricular remodeling in the context of ischemic or idiopathic dilated cardiomyopathy). Degenerative and functional MR are completely different disease entities that pose specific decision-making problems and require different management. The natural history of severe degenerative MR is clearly unfavorable. However, the appropriate and timely correction of degenerative MR is associated with a life expectancy similar to that of the normal population. By contrast, the prognostic impact of the correction of functional MR is still a matter of debate. In this Review, we discuss the optimal treatment of both degenerative and functional MR, taking into account all presently available therapeutic options, including novel percutaneous methods. Since a clear understanding of the etiology and mechanisms of valvular dysfunction is important to guide the timing and choice of treatment, the role of echocardiography in the management of MR is also addressed.
Key Points
-
Degenerative and functional mitral regurgitation (MR) are completely different disease entities, each posing specific challenges with regard to decision-making and management
-
2D and 3D echocardiography capture important physiological information and provide the roadmap for the treatment of patients with MR
-
Surgical mitral valve (MV) repair is the preferred treatment for patients with severe degenerative MR and can improve life expectancy to normal levels if performed adequately and in a timely manner
-
In patients with functional MR, annuloplasty should only be carried out in the presence of echocardiographic predictors of successful repair; MV replacement should be considered when unsatisfactory results are expected
-
Transcatheter correction of MR (MV repair or replacement) represents a novel field of cardiovascular medicine and is expected to change surgical practice in the future
-
Use of the MitraClip® should currently be reserved for patients with functional or degenerative MR who are unsuitable for surgery or have a very high surgical risk
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nkomo, V. T. et al. Burden of valvular heart diseases: a population-based study. Lancet 368, 1005–1011 (2006).
Iung, B. & Vahanian A. Epidemiology of valvular heart disease in the adult. Nat. Rev. Cardiol. 8, 162–172 (2011).
Bursi, F. et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 111, 295–301 (2005).
Grigioni, F., Enriquez-Sarano, M., Zehr, K. J., Bailey, K. R. & Tajik, A. J. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103, 1759–1764 (2001).
Ling, L. H. et al. Clinical outcome of mitral regurgitation due to flail leaflet. N. Engl. J. Med. 335, 1417–1423 (1996).
Detaint, D. et al. Surgical correction of mitral regurgitation in the elderly: outcomes and recent improvements. Circulation 114, 265–272 (2006).
Bonow, R. O. et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 52, e1–e142 (2008).
Vahanian, A. et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur. Heart J. 28, 230–268 (2007).
Iung, B. et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur. Heart J. 24, 1231–1243 (2003).
Monin, J. L. et al. Functional assessment of mitral regurgitation by transthoracic echocardiography using standardized imaging planes. J. Am. Coll. Cardiol. 46, 302–309 (2005).
Foster, G. P. et al. Accurate localization of mitral regurgitant defects using multiplane transesophageal echocardiography. Ann. Thorac. Surg. 65, 1025–1031 (1998).
Grewal, J. et al. Real-time three-dimensional transesophageal echocardiography assessment of mitral valve disease. J. Am. Soc. Echocardiography 22, 34–41 (2009).
La Canna, G. et al. Real-time three-dimensional transesophageal echocardiography for assessment of mitral valve functional anatomy in patients with prolapse-related regurgitation. Am. J. Cardiol. 107, 1365–1374 (2011).
Levine, R. A. et al. Three-dimensional echocardiographic reconstruction of the mitral valve, with implications for the diagnosis of mitral valve prolapse. Circulation 80, 589–598 (1989).
Carpentier, A. Cardiac valve surgery—the “French correction”. J. Thorac. Cardiovasc. Surg. 86, 323–337 (1983).
Kumar, N., Kumar, M. & Duran C. M. A revised terminology for recording surgical findings of the mitral valve. J. Heart Valve Dis. 4, 70–75 (1995).
Flameng, W., Meuris, B., Herijgers, P. & Herregods, M. C. Durability of mitral repair in Barlow disease versus fibroelastic deficiency. J. Thorac. Cardiovasc. Surg. 135, 274–282 (2008).
Enriquez-Sarano, M. et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N. Engl. J. Med. 352, 875–883 (2005).
Barbieri, A. et al. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur. Heart J. 32, 751–759 (2011).
Messika-Zeitoun, D. et al. Left atrial remodelling in mitral regurgitation—methodologic approach, physiological determinants, and outcome implications: a prospective quantitative Doppler-echocardiographic and electron beam-computed tomographic study. Eur. Heart J. 28, 1773–1781 (2007).
Tribouilloy, C. et al. Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets. J. Am. Coll. Cardiol. 54, 1961–1968 (2009).
Pizarro, R. et al. Prospective validation of the prognostic usefulness of brain natriuretic peptide in asymptomatic patients with chronic severe mitral regurgitation. J. Am. Coll. Cardiol. 54, 1099–1106 (2009).
Messika Zeitoun, D. et al. Cardiopulmonary exercise testing determination of functional capacity in mitral regurgitation: physiologic and outcome implications. J. Am. Coll. Cardiol. 47, 2521–2527 (2006).
Lancellotti, P. et al. Importance of left ventricular longitudinal function and functional reserve in patients with degenerative mitral regurgitation: assessment by 2-D speckle tracking. J. Am. Soc. Echocardiogr. 21, 1331–1336 (2008).
Magne, J., Lancellotti, P. & Piérard, L. A. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation 122, 33–41 (2010).
Magne, J., Lancellotti, P. & Piérard, L. A. Exercise-induced changes in degenerative mitral regurgitation. J. Am. Coll. Cardiol. 56, 310–313 (2010).
Montant, P. et al. Long-term survival in asymptomatic patients with severe degenerative mitral regurgitation: a propensity score-based comparison between an early surgical strategy and a conservative treatment approach. J. Thorac. Cardiovasc. Surg. 138, 1339–1348 (2009).
Rosenhek, R. et al. Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 113, 2238–2244 (2006).
Le Tourneau, T. et al. Impact of left atrial volume on clinical outcome in organic mitral regurgitation. J. Am. Coll. Cardiol. 56, 570–578 (2010).
Grigioni, F. et al. Outcomes in mitral regurgitation to flail leaflets: a multicenter European study. JACC Cardiovasc. Imaging 1, 133–141 (2008).
Gillinov, A. M. et al. Valve repair versus valve replacement for degenerative mitral valve disease. J. Thorac. Cardiovasc. Surg. 135, 885–893 (2008).
Adams, D. H. et al. Large annuloplasty rings facilitate mitral valve repair in Barlow's disease. Ann. Thorac. Surg. 82, 2096–2100 (2006).
Gammie, J. S., Bartlett, S. T. & Griffith, B. P. Small-incision mitral valve repair: safe, durable, and approaching perfection. Ann. Surg. 250, 409–415 (2009).
Holzhey, D. M. et al. Minimally invasive versus sternotomy approach for mitral valve surgery in patients greater than 70 years old: a propensity-matched comparison. Ann. Thorac. Surg. 91, 401–405 (2011).
Casselman, F. P. et al. Endoscopic mitral valve repair: feasible, reproducible, and durable. J. Thorac. Cardiovasc. Surg. 125, 273–282 (2003).
Chitwood, W. R. et al. Robotic mitral valve repairs in 300 patients: a single-center experience. J. Thorac. Cardiovasc. Surg. 136, 436–441 (2008).
Gammie, J. S., Bartlett, S. T. & Griffith, B. P. Small-incision mitral valve repair: safe, durable, and approaching perfection. Ann. Surg. 250, 409–415 (2009).
Flameng, W., Herijjers, P. & Bogaerts, K. Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease. Circulation 107, 1609–1613 (2003).
David, T. E. Artificial chordae. Semin. Thorac. Cardiovasc. Surg. 16, 161–168 (2004).
Alfieri, O. et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J. Thorac. Cardiovasc. Surg. 122, 674–681 (2001).
Braunberger, E. et al. Very long-term results (more than 20 years) of valve repair with Carpentier's techniques in nonrheumatic mitral valve insufficiency. Circulation 104 (Suppl. 1), I8–I11 (2001).
Crescenzi, G. et al. Management and decision-making strategy for systolic anterior motion after mitral valve repair. J. Thorac. Cardiovasc. Surg. 137, 320–325 (2009).
Saunders, P. C. et al. Anterior leaflet resection of the mitral valve. Semin. Thorac. Cardiovasc. Surg. 16, 188–193 (2004).
Gillinov, A. M. & Cosgrove, D. M. Chordal transfer for repair of anterior leaflet prolapse. Semin. Thorac. Cardiovasc. Surg. 16, 169–173 (2004).
Dreyfus, G. D., Souza Neto, O. & Aubert, S. Papillary muscle repositioning for repair of anterior leaflet prolapse caused by chordal elongation. J. Thorac. Cardiovasc. Surg. 132, 578–584 (2006).
von Oppell, U. O. & Mohr, F. W. Chordal replacement for both minimally invasive and conventional mitral valve surgery using premeasured Gore-Tex loops. Ann. Thorac. Surg. 70, 2166–2168 (2000).
Zussa, C. Different applications of ePTFE valve chordae: surgical technique. J. Heart Valve Dis. 5, 356–361 (1996).
David, T. E., Armstrong, S. & Sun, Z. Replacement of chordae tendineae with Gore-Tex sutures: a ten-year experience. J. Heart Valve Dis. 5, 352–355 (1996).
Chan, D. T., Chiu C. S., Cheng, L. C. & Au, T. W. Artificial chordae: a simple clip and tie technique. J. Thorac. Cardiovasc. Surg. 136, 1597–1599 (2008).
Salvador, L. et al. A 20-year experience with mitral valve repair with artificial chordae in 608 patients. J. Thorac. Cardiovasc. Surg. 135, 1280–1287 (2008).
Fucci, C. et al. Improved results with mitral valve repair using new surgical techniques. Eur. J. Cardiothorac. Surg. 9, 621–626 (1995).
Kuduvalli, M. et al. Edge-to-edge technique for mitral valve repair: medium-term results with echocardiographic follow-up. Ann. Thorac. Surg. 82, 1356–1361 (2006).
Brinster, D. R. et al. Midterm results of the edge-to-edge technique for complex mitral valve repair. Ann. Thorac. Surg. 81, 1612–1617 (2006).
Bhudia, S. K. et al. Edge-to-edge (Alfieri) mitral repair: results in diverse clinical settings. Ann. Thorac. Surg. 77, 1598–1606 (2004).
Kherani, A. R. et al. Edge-to-edge mitral valve repair: the Columbia Presbyterian experience. Ann. Thorac. Surg. 78, 73–76 (2004).
De Bonis, M. et al. Similar long-term results of mitral valve repair for anterior compared with posterior leaflet prolapse. J. Thorac. Cardiovasc. Surg. 131, 364–368 (2006).
Gillinov, A. M., Shortt, K. G. & Cosgrove D. M. 3rd. Commissural closure for repair of mitral commissural prolapse. Ann. Thorac. Surg. 80, 1135–1136 (2005).
Lapenna, E. et al. Commissural closure for the treatment of commissural mitral valve prolapse or flail. J. Heart Valve Dis. 17, 261–266 (2008).
Maisano, F. et al. The double-orifice technique as a standardized approach to treat mitral regurgitation due to severe myxomatous disease: surgical technique. Eur. J. Cardiothorac. Surg. 17, 201–205 (2000).
Dreyfus, G., Corbi, P. J., Chan, K. M. & Bahrami, T. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann. Thorac. Surg. 79, 127–132 (2005).
Schaff, H. V., Dearani, J. A., Daly, R. C, Orszulak, T. A. & Danielson, G. K. Cox–maze procedure for atrial fibrillation: Mayo Clinic experience. Semin. Thorac. Cardiovasc. Surg. 12, 30–37 (2000).
Raanani, E., Albage, A., David, T. E., Yau, T. M. & Armstrong S. The efficacy of the Cox/maze procedure combined with mitral valve surgery: a matched control study. Eur. J. Cardiothorac. Surg. 19, 438–442 (2001).
Cox, J. L. Intraoperative options for treating atrial fibrillation associated with mitral valve disease. J. Thorac. Cardiovasc. Surg. 122, 212–215 (2001).
Yun, K. L. & Miller, D. C. Mitral valve repair versus replacement. Cardiol. Clin. 9, 315–327 (1991).
Olson, L. J. et al. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin. Proc. 62, 22–34 (1987).
Gammie, J. S. et al. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation 115, 881–887 (2007).
Gillinov, A. M. et al. Should patients with severe degenerative mitral regurgitation delay surgery until symptoms develop? Ann. Thorac. Surg. 90, 481–488 (2010).
Savage, E. B., Ferguson, T. B. Jr &. DiSesa, V. J. Use of mitral valve repair: analysis of contemporary United States experience reported to the Society of Thoracic Surgeons National Cardiac Database. Ann. Thorac. Surg. 75, 820–825 (2003).
David, T. E., Ivanov, J, Armstrong, S., Christie, D. & Rakowski H. A comparison of outcomes of mitral valve repair for degenerative disease with posterior, anterior, and bileaflet prolapse. J. Thorac. Cardiovasc. Surg. 130, 1242–1249 (2005).
Russo, A. et al. Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications. J. Am. Coll. Cardiol. 51, 1203–1211 (2008).
Markar, S. R., Sadat, U., Edmonds, L. & Nair S. K. Mitral valve repair versus replacement in the elderly population. J. Heart Valve Dis. 20, 265–271 (2011).
Nloga, J. et al. Mitral valve surgery in octogenarians: should we fight for repair? A survival and quality-of-life assessment. Eur. J. Cardiothorac. Surg. 39, 875–880 (2011).
Enriquez-Sarano, M. et al. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 90, 830–837 (1994).
Heikkinen, J. et al. Quality of life after mitral valve repair. J. Heart Valve Dis. 14, 722–726 (2005).
Gillinov, A. M. et al. Durability of mitral valve repair for degenerative disease. J. Thorac. Cardiovasc. Surg. 111, 734–743 (1998).
Suri, R. M. et al. Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era. Ann. Thorac. Surg. 82, 819–826 (2006).
Bolling, S. F. et al. Predictors of mitral valve repair: clinical and surgeon factors. Ann. Thorac. Surg. 90, 1904–1911 (2010).
Hueb, A. C. et al. Ventricular remodeling and mitral valve modifications in dilated cardiomyopathy: new insights from anatomic study. J. Thorac. Cardiovasc. Surg. 124, 1216–1224 (2002).
Flynn, M. et al. Regional wall motion abnormalities and scarring in severe functional ischemic mitral regurgitation: a pilot cardiovascular magnetic resonance imaging study. J. Thorac. Cardiovasc. Surg. 137, 1063–1070 (2009).
Lancellotti, P., Gérard, P. & Piérard, L. Long term outcome of patients with heart failure and dynamic mitral regurgitation. Eur. Heart J. 26, 1528–1532 (2005).
Bolling, S. F. et al. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J. Thorac. Cardiovasc. Surg. 109, 676–682 (1995).
Bolling, S. F. et al. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J. Thorac. Cardiovasc. Surg. 115, 381–386 (1998).
Bach, D. & Bolling, S. Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end-stage cardiomyopathy. Am. Heart J. 129, 1165–1170 (1995).
Silberman, S. et al. Repair of ischemic mitral regurgitation: comparison between flexible and rigid annuloplasty rings. Ann. Thorac. Surg. 87, 1721–1726 (2009).
Spoor, M. T., Geltz, A. & Bolling, S. F. Flexible versus nonflexible mitral valve rings for congestive heart failure: differential durability of repair. Circulation 114 (Suppl. 1), I67–I71 (2006).
Bax, J. J. et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation 110 (Suppl. 1), II103–II108 (2004).
Braun, J. et al. Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann. Thorac. Surg. 85, 430–436 (2008).
Wu, A. H. et al. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J. Am. Coll. Cardiol. 45, 381–387 (2005).
McGee, E. C. et al. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J. Thorac. Cardiovasc. Surg. 128, 916–924 (2004).
Hung, J. et al. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target. Circulation 110 (Suppl. 1), II85–II90 (2004).
Magne, J. et al. Preoperative posterior leaflet angle accurately predicts outcome after restrictive mitral valve annuloplasty for ischemic mitral regurgitation. Circulation 115, 782–791 (2007).
Lee, A. P. et al. Mechanisms of recurrent functional mitral regurgitation after mitral valve repair in nonischemic dilated cardiomyopathy: importance of distal anterior leaflet tethering. Circulation 119, 2606–2614 (2009).
Braun, J. et al. Preoperative left ventricular dimensions predict reverse remodelling following restrictive mitral annuloplasty in ischaemic mitral regurgitation. Eur. J. Cardiothorac. Surg. 27, 847–853 (2005).
Roshanali, F., Mandegar, M. H., Yousefnia, M. A., Rayatzadeh, H. & Alaeddini, F. A prospective study of predicting factors in ischemic mitral regurgitation recurrence after ring annuloplasty. Ann. Thor. Surg. 84, 745–749 (2007).
Ciarka, A. et al. Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral valve annuloplasty. Am. J. Cardiol. 106, 395–401 (2010).
Borger, M. A. et al. Initial results of the chordal-cutting operation for ischemic mitral regurgitation. J. Thorac. Cardiovasc. Surg. 133, 1483–1492 (2007).
Hvass, U., Tapia, M., Baron, F., Pouzet, B. & Shafy, A. Papillary muscle sling: a new functional approach to mitral repair in patients with ischemic left ventricular dysfunction and functional mitral regurgitation. Ann. Thorac. Surg. 75, 809–811 (2003).
Kron, I. L., Green, G. R. & Cope, J. T. Surgical relocation of the posterior papillary muscle in chronic ischemic mitral regurgitation. Ann. Thorac. Surg. 74, 600–601 (2002).
Menicanti, L. et al. Ischemic mitral regurgitation: intraventricular papillary muscle imbrication without mitral ring during left ventricular restoration. J. Thorac. Cardiovasc. Surg. 123, 1041–1050 (2002).
De Bonis, M. et al. Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy: role of the “edge-to-edge” technique. Circulation 112 (Suppl. 9), I402–I408 (2005).
Mann, D. L. et al. Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy. Ann. Thorac. Surg. 84, 1226–1235 (2007).
Tulner, S. A. et al. Clinical efficacy of surgical heart failure therapy by ventricular restoration and restrictive mitral annuloplasty. J. Card. Fail. 13, 178–183 (2007).
Vassileva, C. M., Boley, T., Markwell, S. & Hazelrigg, S. Meta-analysis of short-term and long-term survival following repair versus replacement for ischemic mitral regurgitation. Eur. J. Cardiothorac. Surg. 39, 295–303 (2011).
Gillinov, A. M. et al. Is repair preferable to replacement for ischemic mitral regurgitation? J. Thorac. Cardiovasc. Surg. 122, 1125–1141 (2001).
De Bonis, M. & Alfieri, O. Mitral regurgitation should be corrected in patients with dilated cardiomyopathy. Nat. Clin. Pract. Cardiovasc. Med. 5, 452–453 (2008).
Bach, D. S., Awais, M., Gurm, H. S. & Kohnstamm, S. Failure of guideline adherence for intervention in patients with severe mitral regurgitation. J. Am. Coll. Cardiol. 54, 860–865 (2009).
Mirabel, M. et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur. Heart J. 28, 1358–1365 (2007).
Seiffert, M. et al. Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral position. Catheter. Cardiovasc. Interv. 76, 608–615 (2010).
Nuñez-Gil, I. J. et al. Transapical mitral valve-in-valve implantation: a novel approach guided by three-dimensional transoesophageal echocardiography. Eur. J. Echocardiogr. 12, 335–337 (2011).
Cheung, A. W. et al. Transcatheter transapical mitral valve-in-valve implantations for a failed bioprosthesis: a case series. J. Thorac. Cardiovasc. Surg. 141, 711–715 (2011).
de Weger, A., Ewe, S. H., Delgado, V. & Bax, J. J. First-in-man implantation of a trans-catheter aortic valve in a mitral annuloplasty ring: novel treatment modality for failed mitral valve repair. Eur. J. Cardiothorac. Surg. 39, 1054–1056 (2011).
Kawata, M., Vasilyev, N. V., Perrin, D. P. & del Nido, P. J. Beating-heart mitral valve suture annuloplasty under real-time three-dimensional echocardiography guidance: an ex vivo study. Interact. Cardiovasc. Thorac. Surg. 11, 6–9 (2010).
Swaans, M. J., Post, M. C. & ten Berg, J. M. Transapical repair of mitral valve paravalvular leakage using 3-D transesophageal guidance. Catheter. Cardiovasc. Interv. 77, 121–123 (2011).
Forleo, G. B. et al. Real-time integration of intracardiac echocardiography and 3D electroanatomical mapping to guide catheter ablation of isthmus-dependent atrial flutter in a patient with complete situs inversus and interruption of the inferior vena cava with azygos continuation. J. Interv. Card. Electrophysiol. 30, 273–277 (2011).
Maisano, F. et al. Beating-heart implantation of adjustable length mitral valve chordae: acute and chronic experience in an animal model. Eur. J. Cardiothorac. Surg. 40, 840–847 (2011).
Condado, J. A. et al. Percutaneous edge-to-edge mitral valve repair: 2-year follow-up in the first human case. Catheter. Cardiovasc. Interv. 67, 323–325 (2006).
Feldman, T. et al. Percutaneous repair or surgery for mitral regurgitation. N. Engl. J. Med. 364, 1395–1406 (2011).
Franzen, O. et al. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur. Heart J. 31, 1373–1381 (2010).
Maisano, F. European percutaneous mitral valve therapy experience: acute results in the first 1,000 patients. Data from the European ACCESS Registry: what patients have been treated in Europe? Presented at TCT 2010.
Tamburino, C. et al. Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting. Eur. Heart J. 31, 1382–1389 (2010).
Maisano, F. et al. Surgical isolated edge-to-edge mitral valve repair without annuloplasty: clinical proof of the principle for an endovascular approach. EuroIntervention 2, 181–186 (2006).
Schofer, J. et al. Percutaneous mitral annuloplasty for functional mitral regurgitation results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation 120, 326–333 (2009).
Webb, J. G. et al. Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus. Circulation 113, 851–855 (2006).
Sack, S. et al. Percutaneous transvenous mitral annuloplasty: initial human experience with a novel coronary sinus implant device. Circ. Cardiovasc. Interv. 2, 277–284 (2009).
Lansac, E. et al. Percutaneous mitral annuloplasty through the coronary sinus: an anatomic point of view. J. Thorac. Cardiovasc. Surg. 135, 376–381 (2008).
Webb, J. G. et al. Percutaneous suture edge-to-edge repair of the mitral valve. EuroIntervention 5, 86–89 (2009).
Bajona, P., Katz, W. E., Daly, R. C., Zehr, K. J. & Speziali, G. Beating-heart, off-pump mitral valve repair by implantation of artificial chordae tendineae: an acute in vivo animal study. J. Thorac. Cardiovasc. Surg. 137, 188–193 (2009).
Panic, G. et al. A novel technique for treatment of mitral valve prolapse/flail. J. Thorac. Cardiovasc. Surg. 137, 1568–1570 (2009).
Williams, J. L. et al. Feasibility of myxomatous mitral valve repair using direct leaflet and chordal radiofrequency ablation. J. Interv. Cardiol. 21, 547–554 (2008).
Kim, J. H. et al. Mitral cerclage annuloplasty, a novel transcatheter treatment for secondary mitral valve regurgitation: initial results in swine. J. Am. Coll. Cardiol. 54, 638–651 (2009).
Raman, J., Hare, D., Storer, M. & Hata M. Epicardial cardiac basal annuloplasty: preliminary findings on extra-cardiac mitral valve repair. Heart Lung Circ. 18, 401–406 (2009).
Rahman, S., Eid, N., Murarka, S. & Heuser R. R. Remodeling of the mitral valve using radiofrequency energy: review of a new treatment modality for mitral regurgitation. Cardiovasc. Revasc. Med. 11, 249–259 (2010).
Heuser, R. R., Witzel, T., Dickens, D. & Takeda, P. A. Percutaneous treatment for mitral regurgitation: the QuantumCor system. J. Interv. Cardiol. 21, 178–182 (2008).
Jilaihawi, H. et al. Mitral annular reduction with subablative therapeutic ultrasound: pre-clinical evaluation of the ReCor device. EuroIntervention 6, 54–62 (2010).
Lozonschi, L. et al. Transapical mitral valved stent implantation: A survival series in swine. J. Thorac. Cardiovasc. Surg. 140, 422.e1–426.e1 (2010).
Lutter, G. et al. Mitral valved stent implantation. Eur. J. Cardiothorac. Surg. 38, 350–355 (2010).
Grossi, E. A. et al. Ischemic mitral valve reconstruction and replacement: comparison of long-term survival and complications. J. Thorac. Cardiovasc. Surg. 122, 1107–1124 (2001).
Braun, J. et al. Preoperative left ventricular dimensions predict reverse remodelling following restrictive mitral annuloplasty in ischaemic mitral regurgitation. Eur. J. Cardiothorac. Surg. 27, 847–853 (2005).
Magne, J. et al. Preoperative posterior leaflet angle accurately predicts outcome after restrictive mitral valve annuloplasty for ischemic mitral regurgitation. Circulation 115, 782–791 (2007).
Lee, A. P. et al. Mechanisms of recurrent functional mitral regurgitation after mitral valve repair in nonischemic dilated cardiomyopathy: importance of distal anterior leaflet tethering. Circulation 119, 2606–2614 (2009).
Gelsomino, S. et al. Left ventricular reverse remodeling after undersized mitral ring annuloplasty in patients with ischemic regurgitation. Ann. Thorac. Surg. 85, 1319–1330 (2008).
Author information
Authors and Affiliations
Contributions
All authors contributed equally to researching data for the article, made substantial contributions to the discussion of content, wrote, and reviewed and edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
F. Maisano is, or has been, a consultant and has received honoraria from Abbott, Medtronic, St. Jude Medical, and Valtech Cardio. Additionally, he is a stockholder/director of Valtech Cardio and holds, or has applied for, patents related to the company. G. La Canna has received honoraria from Abbott. O. Alfieri is, or has been, a consultant for Symetis and is a stockholder/director of 4Tech, Edwards Lifesciences, and Valtech Cardio. M. De Bonis declares no competing interests.
Rights and permissions
About this article
Cite this article
De Bonis, M., Maisano, F., Canna, G. et al. Treatment and management of mitral regurgitation. Nat Rev Cardiol 9, 133–146 (2012). https://doi.org/10.1038/nrcardio.2011.169
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2011.169
This article is cited by
-
Transcatheter mitral valve repair: review of current techniques
Indian Journal of Thoracic and Cardiovascular Surgery (2020)
-
Fatigue exhaustion of the mitral valve tissue
Biomechanics and Modeling in Mechanobiology (2019)
-
Cardioband system: a novel percutaneous solution for atrioventricular valve insufficiency
Indian Journal of Thoracic and Cardiovascular Surgery (2018)
-
Design, Analysis and Testing of a Novel Mitral Valve for Transcatheter Implantation
Annals of Biomedical Engineering (2017)
-
Pathophysiology and management of multivalvular disease
Nature Reviews Cardiology (2016)